{"id":1876,"date":"2020-07-30T16:48:39","date_gmt":"2020-07-30T14:48:39","guid":{"rendered":"http:\/\/87.233.229.147\/stimulus\/opzuid\/?post_type=avada_portfolio&#038;p=1781"},"modified":"2025-03-31T13:58:15","modified_gmt":"2025-03-31T11:58:15","slug":"een-nieuwe-biomarker-voor-de-diagnose-van-reumatische-aandoeningen","status":"publish","type":"avada_portfolio","link":"https:\/\/www.stimulus.nl\/opzuid\/avada_portfolio\/een-nieuwe-biomarker-voor-de-diagnose-van-reumatische-aandoeningen\/","title":{"rendered":"Een nieuwe biomarker voor de diagnose van reumatische aandoeningen"},"content":{"rendered":"<p>Doel van het huidige project is het ontwikkelen en exploiteren van een gevalideerde in-vitro diagnostic (IVD) immunologische test voor het nauwkeurig kwantificeren van het eiwit S100A12 in bloed.<\/p>\n","protected":false},"featured_media":2422,"template":"","class_list":["post-1876","avada_portfolio","type-avada_portfolio","status-publish","has-post-thumbnail","hentry","portfolio_program_name-opzuid-2014-2020","portfolio_prioriteit-bevordering-innovatievermogen-mkb","portfolio_regio-noord-brabant"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.stimulus.nl\/opzuid\/wp-json\/wp\/v2\/avada_portfolio\/1876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stimulus.nl\/opzuid\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/www.stimulus.nl\/opzuid\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stimulus.nl\/opzuid\/wp-json\/wp\/v2\/media\/2422"}],"wp:attachment":[{"href":"https:\/\/www.stimulus.nl\/opzuid\/wp-json\/wp\/v2\/media?parent=1876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}